Home infusion for antisense oligonucleotide therapy

被引：0
|
作者：
Romano, E. [1 ]
Ayanoglu, C. Yanar [1 ]
Coskun, T. [1 ]
Eser, G. [1 ]
Topaloglu, H. [1 ]
机构：
[1] Yeditepe Univ, Istanbul, Turkey
来源：
NEUROMUSCULAR DISORDERS | 2022年 / 32卷
关键词：
D O I：
10.1016/j.nmd.2022.07.235
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.119
引用
收藏
页码：S98 / S99
页数：2
相关论文
共 50 条
  • [31] Chronic infusion of antisense NPY oligonucleotide in lean and obese Zucker rats.
    White, BD
    Hausman, D
    Hulsey, MG
    Latimer, M
    Martin, RJ
    FASEB JOURNAL, 1997, 11 (03): : 2040 - 2040
  • [32] Managing Home Infusion Therapy
    Fields, Bronwyn E.
    Whitney, Robin L.
    Bell, Janice F.
    AMERICAN JOURNAL OF NURSING, 2020, 120 (12) : 53 - 59
  • [33] Reviewing antisense oligonucleotide therapy, part 1 - Action and design
    Das, SK
    Miller, KJ
    BIOPHARM-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT, 1999, 12 (10): : 42 - +
  • [34] Fetal antisense oligonucleotide therapy for congenital deafness and vestibular dysfunction
    Wang, Lingyan
    Kempton, J. Beth
    Jiang, Han
    Jodelka, Francine M.
    Brigande, Alev M.
    Dumont, Rachel A.
    Rigo, Frank
    Lentz, Jennifer J.
    Hastings, Michelle L.
    Brigande, John, V
    NUCLEIC ACIDS RESEARCH, 2020, 48 (09) : 5065 - 5080
  • [35] Recent Advances in Antisense Oligonucleotide Therapy in Genetic Neuromuscular Diseases
    Verma, Ashok
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2018, 21 (01) : 3 - 8
  • [36] Reviewing antisense oligonucleotide therapy: part 2, delivery issues
    Das, SK
    Miller, KJ
    BIOPHARM-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT, 1999, 12 (11): : 44 - +
  • [37] Antisense Oligonucleotide Therapy: From Design to the Huntington Disease Clinic
    Rook, Morgan E.
    Southwell, Amber L.
    BIODRUGS, 2022, 36 (02) : 105 - 119
  • [38] Carbohydrate modifications in antisense oligonucleotide therapy: New kids on the block
    Manoharan, M
    Kawasaki, AM
    Prakash, TP
    Fraser, AS
    Prhavc, M
    Inamati, GB
    Casper, MD
    Cook, PD
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 1999, 18 (6-7): : 1737 - 1746
  • [39] Basics of antisense oligonucleotide therapy and current therapeutical strategies in urology
    Kausch, I
    Böhle, A
    AKTUELLE UROLOGIE, 2003, 34 (07) : 458 - 468
  • [40] Antisense Oligonucleotide Therapy against Spinal Muscular Dystrophy approved
    Pacher-Zavisin, Margit C.
    BIOENGINEERED, 2017, 8 (02) : 114 - 114
12345